Primary Record
Nurel-N1
- In stock
- 8,023 g
- Purity
- 99.3 %
- CAS
- 40297-46-9
Compound Identifiers & Properties
- CAS
- 40297-46-9
- PubChem CID
- 218187
- SMILES
- COC1=CC=CC(=C1)NC(=O)CN2CCOCC2
- Canonical SMILES
- COc1cccc(NC(=O)CN2CCOCC2)c1
Names & Synonyms
- Nurel-N1
- DG 2
- RefChem:198751
- NG2-GAD
- 4-Morpholineacetamide, N-(3-methoxyphenyl)-
- 3'-Methoxy-2-morpholinoacetanilide
- D02RBQ
- AC1Q5N4Z
- DG-2
- 759S9Z8LT7
- UNII-759S9Z8LT7
- DTXSID00193305
- NG-2
- SCHEMBL29362316
- DTXCID70115796
- N-(3-Methoxyphenyl)-4-morpholineacetamide
- N-(3-methoxyphenyl)-2-morpholin-4-ylacetamide
- AC1L5464
- AR-1G3853
- CID218187
- STL089714
- ZINC19913547
- AKOS002248569
- C13-H18-N2-O3
- BAS 03017731
- LS-92284
- N-(3-methoxyphenyl)-2-(morpholin-4-yl)acetamide
- ST50752639
- GAD-based gene therapy (pain, NTDDS),Diamyd
- 40297-46-9
- N-(3-Methoxy-phenyl)-2-morpholin-4-yl-acetamide
- N-(3-METHOXYPHENYL)-2-MORPHOLIN-4-YL-ETHANAMIDE
- Glutamic acid decarboxylase-based pain therapy, Diamyd
- Neurotrophic factor-expressing gene therapies (HSV carrier, neuropathy), Nurel
- Neurotrophic factor-expressing gene therapies (HSV carrier, neuropathy/shingles), Diamyd
- 53304-33-9